Russell Gollard Bill Arana Erin Kaltenbrun Paul Tebbey
10.1159/000530132
Case Rep Oncol
2023 Jun 8;16(1):431-437.
cancer vaccine checkpoint inhibition nivolumab non-small-cell lung cancer pd-l1
CC BY-NC
https://pubmed.ncbi.nlm.nih.gov/37384204/
Case Reports
PMC10294266
37384204
Durable Response to Maintenance Treatment Comprised of Viagenpumatucel-L, Nivolumab, Ramucirumab, and Docetaxel in a PD-L1-Low Advanced-Stage Non-Small-Cell Lung Cancer: A Case Report
2023